UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009634
Receipt No. R000010813
Scientific Title Phase II/III study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemotherapy for resectable pancreatic cancer (Prep-02/JSAP-05)
Date of disclosure of the study information 2012/12/26
Last modified on 2019/07/04 09:22:36

No. Disposal Last modified on Item of update
1 Insert 2012/12/26 13:57:29
2 Update 2012/12/26 15:46:39 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
3 Update 2013/01/05 17:02:50 Recruitment status
4 Update 2013/12/26 09:19:15 TEL
Email
Homepage URL
Email
5 Update 2014/06/26 12:12:31 Email1
6 Update 2014/07/28 12:11:03 Email1
7 Update 2016/06/27 12:16:04 Recruitment status
8 Update 2017/12/19 13:45:14 Homepage URL
Email
Email
Name of primary sponsor
Organization
Category of Funding Organization
9 Update 2017/12/19 13:47:15 Last follow-up date
10 Update 2019/07/02 09:38:04 Recruitment status
Date of IRB
11 Update 2019/07/04 09:18:49 Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
12 Update 2019/07/04 09:22:36 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Email

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
Zip code
Organization
Organization
Division name
Division name
Organization
Organization
Address
Address
Tel
Email


Contact us.